C5 and Alzheimer disease: To identify inflammatory plasma biomarkers in mild cognitive impairment (MCI) and AD patients, it has been reported that complement factor H (CFH), complement component C3, and C5 were significantly higher in MCI (n = 199) than control subjects (n = 259).